Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

Non-competitive NMDA receptor antagonists, such as phencyclidine, ketamine and MK801, produce psychosis in humans. These drugs also produce injury to cingulate-retrosplenial cortex in adult rodents that can be prevented by GABA-receptor agonists and antipsychotics such as haloperidol and clozapine. MK801 injections into anterior thalamus reproduce limbic cortex injury, and GABA-receptor agonist injections into anterior thalamus prevent injury produced by systemic MK801. Inhibition of NMDA receptors on GABAergic thalamic reticular nucleus neurons might activate thalamocortical 'injury' circuits in animals. Pathological activation of thalamocortical circuits might also mediate the psychosis produced by NMDA-receptor antagonists in humans, and might contribute to psychosis in schizophrenia.

[1]  R S Kahn,et al.  Partial volume decrease of the thalamus in relatives of patients with schizophrenia. , 1998, The American journal of psychiatry.

[2]  Anthony A Grace,et al.  Gating of information flow within the limbic system and the pathophysiology of schizophrenia , 2000, Brain Research Reviews.

[3]  J. Sharp,et al.  DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex , 1995, Brain Research.

[4]  T. Svensson Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs , 2000, Brain Research Reviews.

[5]  L. Friedman,et al.  Meta-analysis of thalamic size in schizophrenia , 2001, Biological Psychiatry.

[6]  M. Hasselmo,et al.  NMDA-dependent modulation of CA1 local circuit inhibition , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  P. Goldman-Rakic,et al.  D1 receptors in prefrontal cells and circuits , 2000, Brain Research Reviews.

[8]  A. Gonzalo-Ruiz,et al.  Evidence for collateral projections to the retrosplenial granular cortex and thalamic reticular nucleus from glutamate and/or aspartate-containing neurons of the anterior thalamic nuclei in the rat , 1997, Experimental Brain Research.

[9]  P. Goldman-Rakic,et al.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.

[10]  A. Carlsson,et al.  Network interactions in schizophrenia — therapeutic implications , 2000, Brain Research Reviews.

[11]  R. Clark,et al.  Impaired Recognition Memory in Monkeys after Damage Limited to the Hippocampal Region , 2000, The Journal of Neuroscience.

[12]  T Sharma,et al.  Magnetic resonance imaging of the thalamus in first-episode psychosis. , 2001, The American journal of psychiatry.

[13]  H. Holcomb,et al.  The limbic cortex in schizophrenia: focus on the anterior cingulate , 2000, Brain Research Reviews.

[14]  K. Dikranian,et al.  Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity , 2002, Molecular Psychiatry.

[15]  D. German,et al.  Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia , 2000, Biological Psychiatry.

[16]  L R Squire,et al.  Relationship between magnitude of damage to the hippocampus and impaired recognition memory in monkeys , 2001, Hippocampus.

[17]  R. Wise,et al.  Addictive drugs and brain stimulation reward. , 1996, Annual review of neuroscience.

[18]  Molly M. Huntsman,et al.  Nucleus‐ and cell‐specific expression of NMDA and non‐NMDA receptor subunits in monkey thalamus , 1998 .

[19]  D. Goff,et al.  A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia , 1999, Biological Psychiatry.

[20]  R. Auer,et al.  Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats. , 1996, Stroke.

[21]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[22]  N. Andreasen The Role of the Thalamus in Schizophrenia , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[23]  Paul J. Harrison The neuropathology of schizophrenia , 2008 .

[24]  Seth J. Ramus,et al.  Dissociation between the effects of damage to perirhinal cortex and area TE. , 1999, Learning & memory.

[25]  M. Mishkin,et al.  Object Recognition and Location Memory in Monkeys with Excitotoxic Lesions of the Amygdala and Hippocampus , 1998, The Journal of Neuroscience.

[26]  G. Duncan,et al.  Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. , 2000, The Journal of pharmacology and experimental therapeutics.

[27]  M. Mishkin,et al.  Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  A. Belger,et al.  NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. , 1999, Harvard review of psychiatry.

[29]  K. L. Leenders,et al.  Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) , 1997, European Neuropsychopharmacology.

[30]  L. Noble,et al.  MK‐801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex , 1991, Annals of neurology.

[31]  D. Gaffan Scene-Specific Memory for Objects: A Model of Episodic Memory Impairment in Monkeys with Fornix Transection , 1994, Journal of Cognitive Neuroscience.

[32]  C. Tamminga Glutamatergic aspects of schizophrenia , 1999, British Journal of Psychiatry.

[33]  D. Barber,et al.  Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: A neural substrate for psychosis? , 1998, Neuroscience.

[34]  L. Lindström Schizophrenia, the dopamine hypothesis and α2-adrenoceptor antagonists , 2000 .

[35]  J. Asarnow,et al.  Childhood-Onset Schizophrenia , 1994 .

[36]  B. Pakkenberg,et al.  Stereological studies of the schizophrenic brain , 2000, Brain Research Reviews.

[37]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[38]  J. Ringo Seemingly discrepant data from hippocampectomized macaques are reconciled by detectability analysis. , 1988, Behavioral neuroscience.

[39]  M Meunier,et al.  Effects of rhinal cortex lesions combined with hippocampectomy on visual recognition memory in rhesus monkeys. , 1996, Journal of neurophysiology.

[40]  K. Hashimoto,et al.  Regionally different effects of scopolamine on NMDA antagonist-induced heat shock protein HSP70 , 1997, Brain Research.

[41]  G. Aghajanian,et al.  Serotonin model of schizophrenia: emerging role of glutamate mechanisms , 2000, Brain Research Reviews.

[42]  L. Squire,et al.  Damage to the perirhinal cortex exacerbates memory impairment following lesions to the hippocampal formation , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  J. Olney,et al.  Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity , 1993, Biological Psychiatry.

[44]  R. Guillery,et al.  Paying attention to the thalamic reticular nucleus , 1998, Trends in Neurosciences.

[45]  D. Gaffan,et al.  Dense amnesia in the monkey after transection of fornix, amygdala and anterior temporal stem , 2001, Neuropsychologia.

[46]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[47]  J. Newcomer,et al.  NMDA receptor hypofunction model of schizophrenia. , 1999, Journal of psychiatric research.

[48]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[49]  F. Sharp,et al.  Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK‐801) injures pyramidal neurons in rat retrosplenial cortex , 2000, The European journal of neuroscience.

[50]  Olney Jw NEUROTOXICITY OF NMDA RECEPTOR ANTAGONISTS : AN OVERVIEW , 1994 .

[51]  Molly M. Huntsman,et al.  Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics , 1998 .

[52]  D. Lewis GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia , 2000, Brain Research Reviews.

[53]  R. Murray,et al.  Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. , 2000, Archives of general psychiatry.

[54]  J. Olney,et al.  Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity , 1998, Neuropsychopharmacology.

[55]  A. Sampson,et al.  GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. , 2001, The American journal of psychiatry.

[56]  J. Sharp,et al.  Effects of sigma ligands on the ability of rimcazole to inhibit PCP hsp70 induction , 1996, Brain Research Bulletin.

[57]  A. Harris,et al.  Critical review of GABA-ergic drugs in the treatment of schizophrenia. , 1999, Journal of clinical psychopharmacology.

[58]  Jones Eg A new view of specific and nonspecific thalamocortical connections. , 1998 .

[59]  F. Sharp,et al.  Acute phencyclidine neurotoxicity in rat forebrain: induction of haem oxygenase‐1 and attenuation by the antioxidant dimethylthiourea , 1998, The European journal of neuroscience.

[60]  Seth J. Ramus,et al.  Severity of memory impairment in monkeys as a function of locus and extent of damage within the medial temporal lobe memory system , 1994, Hippocampus.

[61]  J. Olney,et al.  Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. , 1994, The Journal of clinical psychiatry.

[62]  E G Jones,et al.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[63]  L. Noble,et al.  Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine , 1992, Journal of neuroscience research.

[64]  E. Murray,et al.  Effects of hippocampal lesions on delayed nonmatching‐to‐sample in monkeys: A reply to Zola and Squire (2001) † , 2001, Hippocampus.

[65]  E. Murray,et al.  Opposite relationship of hippocampal and rhinal cortex damage to delayed nonmatching‐to‐sample deficits in monkeys † , 2001, Hippocampus.

[66]  L. Squire,et al.  Memory impairment in monkeys following lesions limited to the hippocampus. , 1986, Behavioral neuroscience.

[67]  B. Bogerts,et al.  Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons , 1998, Psychiatry Research: Neuroimaging.

[68]  J. Olney,et al.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.

[69]  F. Benes,et al.  Emerging principles of altered neural circuitry in schizophrenia , 2000, Brain Research Reviews.

[70]  J L Rapoport,et al.  Childhood-Onset Schizophrenia: Progressive Ventricular Change During Adolescence , 1997 .

[71]  N. Andreasen,et al.  Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients , 1997, The Lancet.

[72]  F. Sharp,et al.  Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels , 1994, Neuroscience.

[73]  J. Olney,et al.  Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity , 1996, Schizophrenia Research.

[74]  Takeshi Kawahara,et al.  Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex , 1998 .

[75]  R. Killiany,et al.  Hippocampal formation lesions produce memory impairment in the rhesus monkey , 1999, Hippocampus.

[76]  I. Feinberg,et al.  Intraperitoneal dizocilpine induces cortical spike-wave seizure discharges in rats , 1995, Neuroscience Letters.